Cresp 500mcg Darbepoetin ALFA Injection

Cresp 500mcg Darbepoetin Alfa Injection is a prescription medication used to treat anemia associated with chronic kidney disease (CKD) and anemia caused by certain chemotherapy treatments. It contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) that helps stimulate the bone marrow to produce more red blood cells. By increasing red blood cell production, Cresp 500mcg Darbepoetin Alfa Injection improves oxygen delivery throughout the body, helping to reduce symptoms such as fatigue, weakness, dizziness, and shortness of breath. Administered as a subcutaneous or intravenous injection under the supervision of a healthcare professional, it plays an important role in the management of anemia and supports improved patient well-being. Regular monitoring of hemoglobin levels is essential during treatment to ensure safe and effective use. Patients should use Cresp 500mcg Injection only as directed by their healthcare provider.